Invesco Biotechnology & Genome ETF
PBE
PBE
99 hedge funds and large institutions have $80.9M invested in Invesco Biotechnology & Genome ETF in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
99
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$987K | |
| 2 | +$840K | |
| 3 | +$693K | |
| 4 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$266K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$226K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$1.22M | |
| 3 | -$854K | |
| 4 |
Two Sigma Investments
New York
|
-$739K |
| 5 |
GKWIM
Gerber Kawasaki Wealth & Investment Management
Santa Monica,
California
|
-$620K |
